Pfizer, others to bridge the gap in cancer treatment
To close the affordability gap for patients and increase their access to cancer treatments, Pfizer has partnered with the American Cancer Society and the Clinton Health Access Initiative (CHAI).
Country Director and Head of West Africa Cluster, Pfizer, Olayinka Subair, who disclosed in a press release, said the partnership’s goal is to lower the price of 16 priority, quality-assured drugs. by nearly 50 percent in six countries in Africa.
To address the challenges of financing and accessing healthcare, Subair said Pfizer has partnered with mPharma on the “Taksit” project, a new payment program, which allows patients to pay in installments. “The Taksit project offers patients immediate access to their medication while allowing them to pay over 30 days, the majority of registrants being patients paying out-of-pocket and insured patients whose plan does not cover the entire length of their stay at the hospital. The program is underway in more than 20 hospitals with plans to expand, ”added the country official.
Pfizer also launched Project Afya, a patient assistance program aimed at improving access to life-saving medicines and boosting cancer care and management of autoimmune diseases, Subair said, adding that Project Afya supports patients suffering from two diseases, namely oncology (especially breast cancer). and rheumatoid arthritis in low-income urban and rural areas.
In partnership with IQVIA, Subair said the platform is helping reduce treatment costs for eligible patients with the support of government health insurance in collaboration with key partners such as NGOs and charities. He said universal health care coverage in Nigeria has seen serious setbacks, with the majority of the population paying out of pocket, while assuring that the breakthrough therapies offered by Pfizer as part of the Afya Project aim to expand and dramatically improve people’s lives.
He said: “The Afya project is particularly important for a country like Nigeria, where research shows that breast cancer accounts for 16.4% of the cancer death rate, followed by cervical cancer (12 %) and prostate cancer (11%) and autoimmune diseases such as rheumatoid are an important medical condition in Nigeria, mainly affecting women.
“The project aims to alleviate some of the pressure on the country’s already overburdened health system, where large numbers of people need better access to specialized medicines. Closing this health care gap will go a long way in improving treatment outcomes. “
Subair assured that the various patient assistance programs would help patients start, continue and finish their treatments.